Cargando…
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311165/ https://www.ncbi.nlm.nih.gov/pubmed/35278253 http://dx.doi.org/10.1111/cea.14121 |
| _version_ | 1784753546776805376 |
|---|---|
| author | Ghazanfar, Misbah Noshela Bartko, Ewa Anna Arildsen, Nicolai Skovbjerg Poulsen, Lars K. Jensen, Bettina Margrethe Enevold, Christian Holm, Jesper Grønlund Woetmann, Anders Ødum, Niels Thomsen, Simon Francis |
| author_facet | Ghazanfar, Misbah Noshela Bartko, Ewa Anna Arildsen, Nicolai Skovbjerg Poulsen, Lars K. Jensen, Bettina Margrethe Enevold, Christian Holm, Jesper Grønlund Woetmann, Anders Ødum, Niels Thomsen, Simon Francis |
| author_sort | Ghazanfar, Misbah Noshela |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9311165 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93111652022-07-29 Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study Ghazanfar, Misbah Noshela Bartko, Ewa Anna Arildsen, Nicolai Skovbjerg Poulsen, Lars K. Jensen, Bettina Margrethe Enevold, Christian Holm, Jesper Grønlund Woetmann, Anders Ødum, Niels Thomsen, Simon Francis Clin Exp Allergy Research Letters John Wiley and Sons Inc. 2022-03-22 2022-05 /pmc/articles/PMC9311165/ /pubmed/35278253 http://dx.doi.org/10.1111/cea.14121 Text en © 2022 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Research Letters Ghazanfar, Misbah Noshela Bartko, Ewa Anna Arildsen, Nicolai Skovbjerg Poulsen, Lars K. Jensen, Bettina Margrethe Enevold, Christian Holm, Jesper Grønlund Woetmann, Anders Ødum, Niels Thomsen, Simon Francis Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study |
| title | Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study |
| title_full | Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study |
| title_fullStr | Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study |
| title_full_unstemmed | Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study |
| title_short | Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study |
| title_sort | omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: a three‐month prospective study |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311165/ https://www.ncbi.nlm.nih.gov/pubmed/35278253 http://dx.doi.org/10.1111/cea.14121 |
| work_keys_str_mv | AT ghazanfarmisbahnoshela omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT bartkoewaanna omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT arildsennicolaiskovbjerg omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT poulsenlarsk omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT jensenbettinamargrethe omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT enevoldchristian omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT holmjespergrønlund omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT woetmannanders omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT ødumniels omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy AT thomsensimonfrancis omalizumabserumlevelspredicttreatmentoutcomesinpatientswithchronicspontaneousurticariaathreemonthprospectivestudy |